Ginkgo Bioworks Holdings Inc
Change company Symbol lookup
Select an option...
DNA Ginkgo Bioworks Holdings Inc
BRCC BRC Inc
FSMAX Fidelity® Extended Market Index Fund
PFE Pfizer Inc
DUNE Dune Acquisition Corp
METV Roundhill Ball Metaverse ETF
TBNK Territorial Bancorp Inc
BAC Bank of America Corp
ICD Independence Contract Drilling Inc
NOK Nokia Oyj
Go

Company profile

Ginkgo Bioworks Holdings, Inc., formerly Spinning Eagle Acquisition Corp, is engaged in building a platform to program cells. The Company's platform is used to program cells on behalf of its customers. Its cell programs are designed to enable biological production of products such as therapeutics, key food ingredients, and chemicals derived from petroleum. The Company's platform is used to design, write, and debug deoxyribonucleic acid (DNA) code in engineered organisms to execute programs for its customers. The Company’s platform comprises of equipment, robotic automation, software, data pipelines and tools, and standard operating procedures for genetic engineering, fermentation, and analytics, a library of proprietary genetic assets and associated performance data; and developers and operators of the foundry and codebase. It serves industries, including chemicals, agriculture, food, consumer products, and pharmaceuticals.

Postmarket

Last Trade
Delayed
$2.80
0.06 (2.19%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$2.74
Day's Change
0.31 (12.76%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.84
Day's Low
2.42
Volume
(Heavy Day)
Volume:
34,624,644

10-day average volume:
24,964,301
34,624,644

Company Profile

Ginkgo Bioworks Holdings, Inc., formerly Spinning Eagle Acquisition Corp, is engaged in building a platform to program cells. The Company's platform is used to program cells on behalf of its customers. Its cell programs are designed to enable biological production of products such as therapeutics, key food ingredients, and chemicals derived from petroleum. The Company's platform is used to design, write, and debug deoxyribonucleic acid (DNA) code in engineered organisms to execute programs for its customers. The Company’s platform comprises of equipment, robotic automation, software, data pipelines and tools, and standard operating procedures for genetic engineering, fermentation, and analytics, a library of proprietary genetic assets and associated performance data; and developers and operators of the foundry and codebase. It serves industries, including chemicals, agriculture, food, consumer products, and pharmaceuticals.

Valuation Ratios

Price/Earnings (TTM)
--
Price/Sales (TTM)
10.43x
Price/Book (MRQ)
2.35x
Price/Cash Flow (TTM)
--
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

No historic growth available.

Short Interest

April 2022
Current Month
92.5M
Previous Month
81.3M
Percent of Float
10.59%
Days to Cover
5.2733 Days

Share Information

DNA is in a share class of common stock
Float
856.4M
Shares Outstanding
1.5B
Institutions Holding Shares
203
74.99%

Financial Statements

Balance sheet

Values displayed are in millions.

Income statement

Values displayed are in millions.

Cash flow

Values displayed are in millions.

Company Officers

No company officers listed.

Address

  • 27 Drydock Avenue, 8Th Floor
  • Boston, MA 02210
  • Phone: (310) 209-7280
  • Fax: (302) 655-5049

Insider Trading

No insider trading activity.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.